Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers.

María Jesús Arranz Juliana SalazarValentin BoteAlicia Artigas-BaleriAlexandre Serra-LLovichEmma TriviñoJordi RoigeCarlos LombardiaMartha CancinoMarta H Hernández Marc CendrosEnric Duran-TauleriaNatalia MaraverAmaia Hervas

Published in: Pharmaceutics (2022)

The implementation of pharmacogenetic interventions has the potential to significantly improve the clinical outcomes in severe comorbid ASD populations with drug treatment resistance and poor prognosis.

Keyphrases

poor prognosis
spectrum disorder
long non coding rna
physical activity
autism spectrum disorder
primary care
healthcare
attention deficit hyperactivity disorder
early onset
drug induced
quality improvement
risk assessment
human health
combination therapy